CIK 0001856725 · <br>Emerging growth company
Rani Therapeutics Holdings, Inc.
Sign in to watch- Ticker
- RANI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 863114789
- Phone
- (408) 457-3700
- Business address
- 47709 FREMONT BLVD, FREMONT, CA, 94538
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 63 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-16 | Hashim Mir Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +83,724 | 83,724 | ||
| 2023-12-16 | Imran Talat Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −479,667 | 95,933 | ||
| 2023-12-16 | Imran Talat Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +479,667 | 479,667 | ||
| 2023-12-16 | Imran Talat Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −153,650 | 109,750 | ||
| 2023-12-16 | Imran Talat Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +153,650 | 153,650 | ||
| 2023-12-16 | Imran Talat Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −271,875 | 453,125 | ||
| 2023-12-16 | Imran Talat Chief Executive Officer | Grant or award · 271875 | +271,875 | 271,875 | ||
| 2023-12-16 | Imran Talat Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −31,252 | 47,699 | ||
| 2023-12-16 | Imran Talat Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +31,252 | 31,252 | ||
| 2023-12-16 | Ausiello Dennis A Director | Returned to the company · Stock Option (Right to Buy) | −101,276 | 0 | ||
| 2023-12-16 | Ausiello Dennis A Director | Grant or award · Stock Option (Right to Buy) | +101,276 | 101,276 | ||
| 2023-12-16 | Ausiello Dennis A Director | Returned to the company · Stock Option (Right to Buy) | −15,423 | 63,894 | ||
| 2023-12-16 | Ausiello Dennis A Director | Grant or award · Stock Option (Right to Buy) | +15,423 | 15,423 | ||
| 2023-12-16 | DEBUONO LAUREEN Director | Returned to the company · Stock Option (Right to Buy) | −101,276 | 0 | ||
| 2023-12-16 | DEBUONO LAUREEN Director | Grant or award · Stock Option (Right to Buy) | +101,276 | 101,276 | ||
| 2023-12-16 | DEBUONO LAUREEN Director | Returned to the company · Stock Option (Right to Buy) | −18,875 | 117,021 | ||
| 2023-12-16 | DEBUONO LAUREEN Director | Grant or award · Stock Option (Right to Buy) | +18,875 | 18,875 | ||
| 2023-12-16 | BUTEL JEAN LUC Director | Returned to the company · Stock Option (Right to Buy) | −101,276 | 0 | ||
| 2023-12-16 | BUTEL JEAN LUC Director | Grant or award · Stock Option (Right to Buy) | +101,276 | 101,276 | ||
| 2023-12-16 | BUTEL JEAN LUC Director | Returned to the company · Stock Option (Right to Buy) | −18,875 | 117,021 |
Page 6 of 9 · 178 trades